N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide

C99H102F9N19O18S — CID 160916906

IUPACN-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide
SMILESCC(C)Oc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.CCNC(=O)N1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.N#Cc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1CCS(=O)(=O)CC1)c1cccc(C(F)F)c1
InChIInChI=1S/C27H30F2N6O4.C25H28F2N4O5.C24H24F2N4O5S.C23H20F3N5O4/c1-2-30-27(38)33-10-8-19(9-11-33)35-22-7-6-20(34-12-13-39-16-23(34)36)15-21(22)31-26(35)32-25(37)18-5-3-4-17(14-18)24(28)29;1-15(2)36-21-13-19-18(12-20(21)30-8-10-35-14-22(30)33)28-25(31(19)7-4-9-32)29-24(34)17-6-3-5-16(11-17)23(26)27;25-22(26)15-2-1-3-16(12-15)23(32)28-24-27-19-13-18(29-8-9-35-14-21(29)31)4-5-20(19)30(24)17-6-10-36(33,34)11-7-17;24-23(25,26)16-4-1-3-14(9-16)21(34)29-22-28-17-11-18(30-6-8-35-13-20(30)33)15(12-27)10-19(17)31(22)5-2-7-32/h3-7,14-15,19,24H,2,8-13,16H2,1H3,(H,30,38)(H,31,32,37);3,5-6,11-13,15,23,32H,4,7-10,14H2,1-2H3,(H,28,29,34);1-5,12-13,17,22H,6-11,14H2,(H,27,28,32);1,3-4,9-11,32H,2,5-8,13H2,(H,28,29,34)
InChIKeySRNDEKNCIYISRK-UHFFFAOYSA-N
MW2049.07 g/mol
LogP13.98
Rot. Bonds26

About N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide

N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide (PubChem CID 160916906) has the molecular formula C99H102F9N19O18S and a molecular weight of 2049.07 g/mol. Its IUPAC name is N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide.

Molecular Properties

Compound NameN-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide
PubChem CID160916906
Molecular FormulaC99H102F9N19O18S
Molecular Weight2049.07 g/mol
Exact Mass2047.72
IUPAC NameN-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide
SMILESCC(C)Oc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.CCNC(=O)N1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.N#Cc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1CCS(=O)(=O)CC1)c1cccc(C(F)F)c1
InChIInChI=1S/C27H30F2N6O4.C25H28F2N4O5.C24H24F2N4O5S.C23H20F3N5O4/c1-2-30-27(38)33-10-8-19(9-11-33)35-22-7-6-20(34-12-13-39-16-23(34)36)15-21(22)31-26(35)32-25(37)18-5-3-4-17(14-18)24(28)29;1-15(2)36-21-13-19-18(12-20(21)30-8-10-35-14-22(30)33)28-25(31(19)7-4-9-32)29-24(34)17-6-3-5-16(11-17)23(26)27;25-22(26)15-2-1-3-16(12-15)23(32)28-24-27-19-13-18(29-8-9-35-14-21(29)31)4-5-20(19)30(24)17-6-10-36(33,34)11-7-17;24-23(25,26)16-4-1-3-14(9-16)21(34)29-22-28-17-11-18(30-6-8-35-13-20(30)33)15(12-27)10-19(17)31(22)5-2-7-32/h3-7,14-15,19,24H,2,8-13,16H2,1H3,(H,30,38)(H,31,32,37);3,5-6,11-13,15,23,32H,4,7-10,14H2,1-2H3,(H,28,29,34);1-5,12-13,17,22H,6-11,14H2,(H,27,28,32);1,3-4,9-11,32H,2,5-8,13H2,(H,28,29,34)
InChIKeySRNDEKNCIYISRK-UHFFFAOYSA-N
XLogP13.98
TPSA445.80 Ų
H-Bond Donors7
H-Bond Acceptors27
Rotatable Bonds26
Heavy Atoms146
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002049.07
LogP ≤ 513.98
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1027

Analyze N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide?
The IUPAC name of N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide (CID 160916906) is N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide.
What is the SMILES notation for N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide?
The canonical SMILES for N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide is CC(C)Oc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.CCNC(=O)N1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.N#Cc1cc2c(cc1N1CCOCC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1CCS(=O)(=O)CC1)c1cccc(C(F)F)c1.
What is the InChIKey of N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide?
The InChIKey is SRNDEKNCIYISRK-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H30F2N6O4.C25H28F2N4O5.C24H24F2N4O5S.C23H20F3N5O4/c1-2-30-27(38)33-10-8-19(9-11-33)35-22-7-6-20(34-12-13-39-16-23(34)36)15-21(22)31-26(35)32-25(37)18-5-3-4-17(14-18)24(28)29;1-15(2)36-21-13-19-18(12-20(21)30-8-10-35-14-22(30)33)28-25(31(19)7-4-9-32)29-24(34)17-6-3-5-16(11-17)23(26)27;25-22(26)15-2-1-3-16(12-15)23(32)28-24-27-19-13-18(29-8-9-35-14-21(29)31)4-5-20(19)30(24)17-6-10-36(33,34)11-7-17;24-23(25,26)16-4-1-3-14(9-16)21(34)29-22-28-17-11-18(30-6-8-35-13-20(30)33)15(12-27)10-19(17)31(22)5-2-7-32/h3-7,14-15,19,24H,2,8-13,16H2,1H3,(H,30,38)(H,31,32,37);3,5-6,11-13,15,23,32H,4,7-10,14H2,1-2H3,(H,28,29,34);1-5,12-13,17,22H,6-11,14H2,(H,27,28,32);1,3-4,9-11,32H,2,5-8,13H2,(H,28,29,34).
What are the key properties of N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide?
N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide has a molecular weight of 2049.07 g/mol, XLogP of 13.98, 26 rotatable bonds, 7 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-cyano-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;4-[2-[[3-(difluoromethyl)benzoyl]amino]-5-(3-oxomorpholin-4-yl)benzimidazol-1-yl]-N-ethylpiperidine-1-carboxamide;3-(difluoromethyl)-N-[1-(1,1-dioxothian-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)-6-propan-2-yloxybenzimidazol-2-yl]benzamide is sourced from PubChem (CID 160916906), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).